APTT. Causes of prolonged aPTTs: 1.Spurious (common to many Coag tests): – dilution (saline, Tx), underfilled specimen, clotted, prolonged tourniquet.

Slides:



Advertisements
Similar presentations
Basic coagulation techniques and Quality control issues
Advertisements

Hemostasis, Surgical Bleeding, and Transfusion
Heparin Resistance “Heparin resistance is a term used to describe the situation when patients require unusually high doses of heparin to achieve a therapeutic.
University of North Carolina-Chapel Hill Division of Hematology
Coagulation Bruno Sopko.
Pre-analytical factors that can affect coag test results
Hemostasis: Hemostasis: Hemo/Stasis Hemo=خونStasis=سکون.
HEMOSTAZ Yard. Doç. Dr. Murat ÖRMEN. Vessels Platelets Fibrinolysis/Inhibitors Coagulation Proteins BleedingClotting Hemostaz.
Bleeding time,clotting time, PT, and PTT
Approach to the Bleeding Patient
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
One Stage Factor V Assay
Interactive Session on Clotting Profile Dr P T R Makuloluwa MBBS (Col), MD (Anaesthesiology), FRCA (Lond)
Tests to measure fibrin clot Lecture 9: General Approach in Investigation of Haemostasis.
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
Vitamin K Dr.S.Chakravarty MD. Vitamin K: K1 – phylloquinone – plant source K2 – menaquinone – bacterial source K3 – Menadione – synthetic form.
General Approach of Haemostasis
WARFARIN AN OVERVIEW.
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
MIXING STUDIES General Approach of Haemostasis
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
ACQUIRED COAGULATION ABNORMALITIES
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.
Clotting, Hemostasis, Anticoagulation
Dr. S. Parthasarathy MD DA DNB PhD (physio) Mahatma Gandhi medical college and research institute, puducherry – India Prothrombin time.
Tests to Measure Fibrin formation Mr. Mohammed A. Jaber.
Investigation of Haemostasis MS. c. program Lab-9.
Activated Partial Thromboplastin Time (aPTT)
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
Factor Assays Robert Gosselin MT (ASCP), CLS.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
거핵구 (Megakaryocytic). Thrombocyte(Platelets ) Platelet Satelitism ( 혈소판 위성현상 ) EDTA Pseudothrombocytopenia.
University of North Carolina-Chapel Hill Division of Hematology
Chapter 17 Coagulation Testing
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Coagulation ICU – RLH Mike Cunningham 11 th December 2008.
Approach To Bleeding Disorders In Neonates
General Approach in Investigation of Hemostasis
MLAB Coagulation Keri Brophy-Martinez
Pre-analytical factors that can affect coag test results
Activated Partial Thromboplastin Time (aPTT)
General Approach in Investigation of Hemostasis
One Stage Factor V Assay
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
Anticoagulants in the Treatment of Venous Thromboembolism
General Approach in Investigation of Hemostasis
University of North Carolina-Chapel Hill Division of Hematology
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
Constituents of the blood: Platelets and plasma
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Coagulation Cascade of the Newborn
Activated Partial Thromboplastin Time (aPTT)
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults  Arif H. Kamal, MD, Ayalew.
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
General Principles of Hemostasis Kristine Krafts, M.D.
Principles of Coagulation Screening II
General Approach in Investigation of Hemostasis
Effects of vitamin K antagonists (VKA), such as warfarin, low-molecular-weight heparin (LMWH), and dabigatran, on the coagulation pathway. Effects of vitamin.
Presentation transcript:

APTT

Causes of prolonged aPTTs: 1.Spurious (common to many Coag tests): – dilution (saline, Tx), underfilled specimen, clotted, prolonged tourniquet time – Heparin (therapeutic, SC, lines (esp ICU, dialysis), wrong tube for collection) – Polycythemia (Hct >45 causes citrate ratio to be incorrect) 2.Presence of an inhibitor. – lupus anticoagulant (LAC) - very common esp with Platelin LS reagent as LAC sensitive – VIII or other acquired inhibitor (rare except in Haemophilia centre or elderly patient) 3.Factor deficiency: – Congenital deficiency of 1/more intrinsic clotting factors or vWF (not FVII). – Severe Vitamin K deficiency (II, IX,X) or warfarin overanticoagulation – Liver disease (also reduces AT3, Prot C/S) – includes dys/hypofibrinogenaemia 4.DIC (FDP effect and factor consumption, including fibrinogen) % “normal population” have APTT > NR (by definition) 6.Excess LMWH or danaparoid (Xa activity >> IIa effect), hirudins Causes of shortened APTTs: 1.activated specimen/started to clot (esp NICU samples, check for clots, rebleed) 2.  FVIII (acute phase reactant) 3.delayed analysis UFH Tx patient specimen after collection (release of PF4 neutralises heparin) 4.2.5% pop have APTT <NR (by definition)

Coagulation FactorPlasma ConcentrationPlasma T1/2 Life Fibrinogen  g/ml80-90 hrs Prothrombin  g/ml60-70 hrs Factor V5-10  g/ml15-25 hrs Factor VII0.5  g/ml 4-7 hrs Factor VIII:C  g/ml8-16 hrs Factor IX3  g/ml12-24 hrs Factor X10-15  g/ml40-45 hrs Factor XI2-7  g/ml40-84 hrs Factor XII29-40  g/ml40-60 hrs Factor XIII20  g/ml120 hrs Prekallikrein25-45  g/mlapprox. 35 hrs HMWK70-90  g/ml hrs

PT / INR

Causes of high PT –liver disease –DIC –congenital deficiency: II, V, VII, X or fibrinogen (rare) –nephrotic syndromes (loss of clotting factors) –presence of an inhibitor (factor or rarely LAC) –poorly collected specimen eg. over-filled specimen under-filled specimen –vitamin K deficiency (eg diet/malabsorption) –warfarin –gross over-heparinization Shortened INR’S usually indicate activation of the specimen during collection by skin/traumatic venepuncture

FDPs INTRINSIC EXTRINSIC TCT Fibrinogen Clot Stability Test

TCT

LMWH et al. vs UFH fondaparinux pure anti-Xa SSSSSSSSS UFH >18 saccharide units with sulphonated tail- Xa:IIa 1:1 danaparoid - Xa:IIa 28:1 - not a heparin protamine LMWH mainly <18 saccharide units eg. enoxaparin - Xa:IIa 3.9:1 SSS

Fibrinogen